Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $8.5450, but opened at $9.43. Ambu A/S shares last traded at $9.43, with a volume of 750 shares.
Ambu A/S Price Performance
The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.73 and a current ratio of 2.92. The firm’s fifty day simple moving average is $10.06 and its 200 day simple moving average is $11.65. The stock has a market capitalization of $2.22 billion, a price-to-earnings ratio of 33.68 and a beta of 0.98.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.07 earnings per share (EPS) for the quarter. The company had revenue of $246.39 million during the quarter. Ambu A/S had a net margin of 7.81% and a return on equity of 8.03%.
About Ambu A/S
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Featured Articles
- Five stocks we like better than Ambu A/S
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
- MarketBeat Week in Review – 06/22 – 06/26
- Rocket Lab’s NASA Win Tests Key Support After Sharp Pullback
- AST SpaceMobile Just Nailed a Major Launch—So Why Is the Stock Crashing?
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
